Impact Biomedical CEO presents investor slide deck on Jan 29, 2025; no details available

IMPACT BIOMEDICAL INC.

Slide package furnished as Exhibit 99.1 not included in filing text; no specifics provided.
CEO Frank D. Heuszel provided investor information on January 29, 2025.
No financial metrics, guidance, or operational updates disclosed in the filing body.

item 7.01 item 9.01

IMPACT BIOMEDICAL INC. filing history →

Source: SEC EDGAR

accession 0001493152-25-004161

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.